Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

NCT05469503 is registered in ClinicalTrials.gov with Valbiotis as lead sponsor.

NCT NCT05469503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05469503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
Lead sponsor
Valbiotis
Phase
Not applicable
Overall status
Unknown status
Start date
July 15, 2022
Completion date
December 1, 2024
Enrollment
410 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, elevated blood pressure, metabolic syndrome, prehypertension